The use of sodium bicarbonate has been curtailed because acute administration of sodium bicarbonate impairs cardiac performance, haemodynamics and systemic oxygenation [1] [2] [3] [4] [5] [6] . Depression of cardiac contractility due to sodium bicarbonate has been reported to be more pronounced during respiratory acidosis than during metabolic acidosis [7] [8] [9] [10] . However, these studies were performed using isolated heart muscle preparations, and there are no in vivo studies where cardiac depression due to bicarbonate injections has been examined during respiratory and metabolic acidosis at comparable pHa.
Acute hypercapnia causes progressive cardiovascular stimulation down to a pHa of 6.8 as a result of endogenous catecholamine release 11, 12 . On the other hand, mild metabolic acidosis with a pHa above 7.1 changes neither circulating catecholamine levels, cardiac β-receptor numbers, nor adenylate cyclase activity in the myocardium 13, 14 . These findings suggest different sympathoadrenal environments between respiratory and metabolic acidosis, and that experimental results in vitro may not simply apply to in vivo preparations where the sympathoadrenal response to acid-base disturbances is intact, and haemodynamic variables are under the influence of humoral changes.
Consequently, we have investigated the acute haemodynamic effects of sodium bicarbonate administration in respiratory and metabolic acidosis at a comparable and clinically relevant pHa, and without acidosis in anaesthetized dogs.
METHODS AND MATERIALS
The study protocol was approved by our institutional animal care committee. Twenty-seven adult mongrel dogs of either sex, weighing 8 to 14.5 kg, were studied. All the dogs were anaesthetized with thiamylal 15 mg.kg -1 intravenously and the trachea was intubated. The lungs were mechanically ventilated with room air supplemented with halothane and oxygen through a cuffed tracheal tube, using a volume-cycled animal ventilator (model R-60, Aika Co. Ltd, Tokyo, Japan). End-tidal CO 2 and halothane concentrations were continuously measured (Capnomac Ultima, DATEX™, Helsinki, Finland). Anaesthesia was maintained with end-tidal halothane 0.6 to 0.8% in oxygen and air. Succinylcholine chloride 20 mg was injected intravenously at the time of tracheal intubation followed by 10 mg.h -1 thereafter to produce neuromuscular block. During all measurements, pulmonary arterial blood temperature was maintained between 36.0 and 38.2°C. Lactated Ringer's solution was administered at a constant rate of 10 ml.kg -1 .h -1 during surgical preparation followed by 5 ml.kg -1 .h -1 during haemodynamic measurements.
An intravenous cannula was inserted into a forelimb vein for administration of lactated Ringer's solution. Lead II electrocardiogram (model 2236A, NEC San-ei Instruments Co. Ltd, Tokyo, Japan) was continuously monitored using subcutaneous electrodes throughout the study period. Heart rate was measured on a beat-to-beat basis by a cardiotachometer (model 1321, NEC San-ei Instruments Co. Ltd, Tokyo, Japan) triggered by lead II of the electrocardiogram. Arterial pressure measurement and blood sampling for blood-gas analysis (288 Blood Gas System, CIBA-CORNING, Medfield, MA, U.S.A.) were performed via a right femoral arterial catheter. A flow-directed, balloon-tipped pulmonary artery catheter (5Fr. Thermodilution Catheter, ARROW™, Reading, PA, U.S.A.) was inserted via the right external jugular vein for continuous monitoring of pulmonary artery pressure. Another catheter was positioned in the right atrium from the right femoral vein to continuously monitor right atrial pressure. A 5 Fr gauge catheter-tipped transducer (model MPC-500, Miller Instruments Inc., Houston, U.S.A.) was inserted through the left external jugular vein and positioned in the right ventricle to obtain instantaneous rate of rise in right ventricular pressure (RV dP/dt) using a differential amplifier (model 1323, NEC San-ei Instruments Co. Ltd, Tokyo, Japan).
After the pulmonary trunk was dissected free of the surrounding tissue through a left-sided thoracotomy in the fourth interspace, an electromagnetic flow probe of appropriate size (model FR 12-16 mm, Nihon-Koden Co. Ltd, Tokyo, Japan) was placed around the pulmonary trunk for continuous measurement of pulmonary blood flow (PBF). The flow probe was calibrated with 0.9% saline solution in vitro before implantation, and PBF was measured continuously with a square-wave electromagnetic blood flowmeter (model MFV-3200, Nihon-Koden Co. Ltd, Tokyo, Japan). All recordings were made on the eight-channel recorder (model RECTI-HORIZ-8K, NEC San-ei Instruments Co. Ltd, Tokyo, Japan) throughout the investigation.
The dogs were randomly assigned to one of three groups: non-acidosis (n=9), respiratory acidosis (n=9), or metabolic acidosis (n=9). After a stabilization period of at least two hours, dogs in the nonacidosis group (P a CO 2 4.9-5.7 kPa and base excess > -4 mmol.l -1 ) received 0.9% saline solution 1.2 ml.kg -1 administered into the right atrium over five seconds, and haemodynamic variables were recorded continuously for three minutes. Subsequently, after another stabilization period of 15 minutes, 7% sodium bicarbonate solution 1 mmol.kg -1 (1.2 ml.kg -1 ) was injected over five seconds into the right atrium, and the same haemodynamic measurements were repeated. Ventilator settings were kept constant during these measurements.
Hypercapnia (P a CO 2 8.2 to 10.4 kPa) was induced and maintained by decreasing respiratory rate in the respiratory acidosis group. After a stabilization period of at least two hours, the same haemodynamic measurements were made before and for three minutes after the administration of 0.9% saline solution 1.2 ml.kg -1 . Following another 15 minutes stabilization period, 7% sodium bicarbonate solution 1 mmol.kg -1 (1.2 ml.kg -1 ) was injected over five seconds into the right atrium, and the same haemodynamic measurements were repeated.
Metabolic acidosis of base deficit less than -6 mmol.l -1 was induced and maintained in the metabolic acidosis group by continuous infusion of hydrochloric acid 2N at approximate rate of 10 to 15 ml.h -1 , while P a CO 2 was maintained between 4.9-5.7 kPa. After a stabilization period of at least two hours following establishment of the target metabolic acidosis, 0.9% saline solution 1.2 ml.kg -1 was injected into the right atrium over five seconds, and haemodynamic measurement was made. Following another 15 minutes stabilization period, 7% sodium bicarbonate solution 1 mmol.kg -1 (1.2 ml.kg -1 ) was injected similarly, and the same haemodynamic measurements were repeated.
All values were expressed as mean (SD). Both mean arterial pressure (MAP) and mean pulmonary arterial pressure (MPAP) were calculated by electronic integrations of the pulse pressures. Pulmonary vascular resistance (PVR) was calculated using a standard formula. Analysis of changes in haemodynamic variables from baseline (30 seconds, one and three minutes) and comparisons of data among the three groups (baseline values and maximum changes from baseline) were performed using one-way and two-way ANOVA, respectively, followed by Student's t test with Bonferroni's correction. A P<0.05 was considered as the minimum level of statistical significance.
RESULTS
Arterial pH of the respiratory and the metabolic acidosis groups were significantly less than that of the non-acidosis group (Table 1) . P a CO 2 of the respiratory acidosis group was significantly greater, and base excess of the metabolic acidosis group was significantly less compared with the corresponding variables of the other two groups, while no significant differences were seen in P a O 2 and plasma electrolyte values among the three groups (Table 1 ).
There were no significant differences in any haemodynamic variables among the groups before and after administration of normal saline 1.2 ml.kg -1 ( Table 2 ). Normal saline caused transient but significant enhancement of right ventricular preload (RAP) in all groups, and a significant increase in PBF in the metabolic acidosis group (Table 2, P<0.05). However, these changes disappeared by the end of the threeminute observation period.
Before administration of sodium bicarbonate, no significant differences were seen in any baseline variables among the three groups (Table 3) . Haemodynamic changes in all groups following the administration of 7% sodium bicarbonate 1.2 ml.kg -1 included significant decreases in MAP and RV dP/dtmax, and significant increases in RAP from baseline values within 30 seconds of injection (Table 3 , P<0.05). However, these haemodynamic changes were transient, gradually returned to the baseline values, and at three minutes, rebound increase in PBF were seen in the non-acidosis and the metabolic acidosis groups (Table 3) .
Heart rates were essentially unchanged in all groups. Even thought haemodynamic variables at intervals of 30 seconds, one and three minutes, and maximum changes in MAP, MPAP and RAP after bicarbonate injections were similar among groups (Table 3 and Figure 1) , maximum reduction in RV dP/dtmax and PBF in the metabolic acidosis group were significantly greater than those in the nonacidosis group (Figure 2, P<0.05 ). In addition, one dog in the metabolic acidosis group developed a reduction of RV dP/dtmax to 40% of the baseline value and systolic blood pressure to 50% within 30 seconds of bicarbonate injection. changes persisted for five minutes until they spontaneously returned to the baseline values without further intervention.
DISCUSSION
The results of the present study demonstrated that the cardio-depressant effect of rapid injection of sodium bicarbonate 1 mmol.kg -1 into the right atrium is similar between moderate respiratory and metabolic acidosis at a comparable pHa, but is more pronounced during metaboloic acidosis than at a physiological pHa as determined by PBF and RV dP/dtmax. dP/dtmax is influenced by preload, afterload and heart rate. In our study, however, there were no significant differences between groups in either changes of right ventricular preload (as reflected by RAP) or right ventricular afterload (PVR) at their maximum changes after bicarbonate injection. Since essentially no heart rate changes have been seen in any group during the observation period (Table 3) , these results indicate that significant changes in dP/dtmax and PBF seen in the metabolic acidosis group but not in the respiratory acidosis group, are (5) s in the non-acidosis, respiratory acidosis, and metabolic acidosis groups, respectively. There were no significant differences between the groups. FIGURE 2: maximum changes in instantaneous rate of rise in right ventricular pressure (RV dP/dtmax and pulmonary blood flow (PBF) from baseline values after injections of 7% sodium bicarbonate 1.2 ml.kg -1 into the right atrium in halothane-anaesthetized dogs in the non-acidosis (n=9), respiratory acidosis (n=9), and metabolic acidosis (n=9) groups. The mean (SD) time at which maximum changes in RV dP/dtmax and and PBF occurred were: RV dP/dtmax-16 (2), 15 (3), 19 (4) 2; PBF-17 (4), 18 (3), 19 (5) s in the non-acidosis, respiratory acidosis, and metabolic acidosis groups, respectively. *P<0,05 versus the non-acidosis group.
likely to be explained by depression of myocardial contractility. Such cardio-depressant effect is considered to be due to a rapid fall in intracellular pH of myocardium caused by free CO 2 diffusion liberated from sodium bicarbonate 15, 16 , and not simply due to the effect of rapid bolus injection as cardiac depression was not duplicated by the same volume of normal saline.
The detrimental haemodynamic changes were transient, and may not be clinically significant. However, at maximum depression following bicarbonate injection, the decrease in PBF observed during metabolic acidosis was threefold greater than that seen under normal acid-base status. In addition, one of the dogs in the metabolic group developed prolonged depression of the myocardium with profound hypotension for five minutes. These results imply that close attention should be paid for a possible haemodynamic perturbation when sodium bicarbonate is injected as a rapid bolus to correct metabolic acidosis in clinical situations.
In contrast to the present study, several in vitro studies using a variety of animal preparations have suggested that sodium bicarbonate causes greater depressions of cardiac performance during respiratory acidosis than metabolic acidosis of comparable extracellular pH [7] [8] [9] [10] . This has been explained by the fact that intracellular pH of the myocardium during respiratory acidosis is lower than that during metabolic acidosis of similar extracellular pH 10 . At least three factors may account for the difference from our results in which more pronounced cardiac depression was demonstrated during metabolic acidosis. Firstly, with an intact physiological response, plasma catecholamine levels are elevated during marked hypercapnia in halothane-anaesthetized dogs 12 . A negative inotropic effect of sodium bicarbonate may have been alleviated in part by such neuronal or adrenal medullary responses. Though in our study sympathetic stimulation due to hypercapnia in the respiratory acidosis group was not evident from the baseline haemodynamic variables, cardiac depression due to intracellular acidosis per se from hypercapnia may have counteracted cardiovascular stimulation caused by increases in plasma catecholamines. Secondly, baseline sympathoadrenal function during metabolic acidosis may be different depending on the time of observation in the study design. Wildenthal et al 17 examined changes in left ventricular function under conditions of constant heart rate, aortic pressure, and flow in dogs during acute lactic acidosis, and found a biphasic course of contractility changes over time. It is possible, therefore, that previous conflicting results in negative inotropic effects of sodium bicarbonate may be interpreted in part as differences in the baseline sympathoadrenal environment at the time of the observations. In our study a two-hour period following establishment of acidosis was ensured before measurements of haemodynamic changes to obtain stable conditions. Lastly, the report by Nishikawa 18 demonstrated in an in vivo canine preparation that bolus administration of sodium bicarbonate 1 mmol.kg -1 produced a greater reduction in pulmonary blood flow during respiratory acidosis than during metabolic acidosis or without acidosis. However, in that study pHa of the respiratory acidosis group was significantly less than that of the metabolic acidosis group.
The results of our study must be interpreted with some constraints.
1. The interpretation of present results should be confined to the dose of bicarbonate studied. Slower speed of injection or small incremental doses are likely to have resulted in less depression of cardiac performance 3 . However, the dose of bicarbonate used in this study has been employed in previous reports as well as being recommended in certain situations of cardiopulmonary resuscitation 1, 3, 19 . 2. The degree of metabolic or respiratory acidosis studied is not expected to produce significant cardiovascular effects 11, 13, 17, 20 , as reflected in our study by similar baseline haemodynamic variables among groups. With more extreme acidosis of either type and where depression of baseline cardiac performance is apparent 11 , detrimental haemodynamic effects of sodium bicarbonate could have been exaggerated.
3. It is not clear from our study why MAP and PBF tended to improve over time following sodium bicarbonate injection (Table 3) . It was not due to the volume effect of sodium bicarbonate since an equal amount of normal saline (0.9%) did not duplicate the phenomenon. However, the greater amount of sodium in sodium bicarbonate (7%) could have expanded plasma volume to a greater extent. Injection of bicarbonate causes release of CO 2 which freely diffuses into myocardium causing an initial decrease in intracellular pH and myocardial contractility. Subsequent gradual improvement in intracellular pH may explain restoration or improvement of cardiac performance following bicarbonate injection 16 . 4. Another possible explanation is that a rapid increase in P a CO 2 due to liberation of CO 2 from bicarbonate may have produced transient cardiovascular stimulation. Administration of hydrochloric acid induces extracellular acidosis while the genesis of acidosis in clinical situations is intracellular.
However, significantly greater cardiac depression with bicarbonate administration in the metabolic acidosis group than the non-acidosis group suggests a marginally disturbed intracellular environment by maintaining extracellular pHa at 7.2 for two hours or longer. Indeed, in an in vivo experiment using rabbits, intravenous infusion of hydrochloric acid followed by one hour equilibration period produced dosedependent linear decreases in intracellular pH of left ventricular myocardium 21 . 5. Halothane, a potent inhibitor of cardiovascular function 22 as well as arterial baroreceptor function 23 , was used in our study.
Finally, decreasing minute ventilation in the respiratory acidosis group would have modified transthoracic pressure relationship between groups. The effects of changes in intra-thoracic pressure on haemodynamic variables should, however, have been minimal in the open-chest preparation.
In conclusion, the impairment of cardiac performance due to acute administration of sodium bicarbonate 1 mmol.kg -1 is comparable between moderate respiratory acidosis and physiological pHa, but is more pronounced during metabolic acidosis than without acidosis in halothane-anaesthetized dogs.
